Mood stabilizer / anticonvulsant

Depakote (valproate / divalproex sodium) Withdrawal

Depakote does not produce a classical withdrawal syndrome. As with other mood stabilizers and anticonvulsants, the clinically important risks on discontinuation are mood relapse in bipolar patients and seizure recurrence in epilepsy patients. Slow tapering is the standard.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~9-16 hours.

Withdrawal timeline

Onset— Days to weeks

No acute withdrawal symptoms.

Peak risk window— Weeks 2-8

Mood relapse or seizure recurrence typically emerges in this window.

Resolution— Variable

Re-stabilization depends on alternative treatment.

Common symptoms

  • Return of underlying condition
  • Sleep disturbance
  • Mood changes

Less common

  • GI changes
  • Tremor changes

Tapering guidance

  • A typical taper reduces by 250 mg every 1-2 weeks.
  • Plan alternative mood stabilization for bipolar patients before tapering.
  • Coordinate any taper with the prescribing physician.

Where ketamine therapy fits

Depakote is compatible with at-home ketamine therapy. Continue Depakote as prescribed during ketamine treatment unless the prescribing psychiatrist advises otherwise.

Check ketamine therapy eligibilityMedication safety with ketamine

Frequently asked questions

Does Depakote have a withdrawal syndrome?

Not in the SSRI sense. The clinically important risks are return of bipolar symptoms or seizure recurrence.

Is Depakote compatible with ketamine therapy?

Yes. Continue as prescribed unless your physician advises otherwise.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.